Thus, the other symptoms are rarely present both in our identified subtypes as well as in the complete LRRK2 data, including MPTP Exposure, Babinski Sign, Severe levodopa-induced chorea, Neuroleptic treatment at the onset of symptoms, history repeated strokes with the stepwise progression of Parkinsonian features, Sustained remission, Oculogyric crisis, Supranuclear gaze palsy or slowing of vertical saccades, Cerebellar signs, History of definite encephalitis, History of strictly unilateral features after three years. Here, LRRK2 is linked to choreatic disease.